The nanoprodrug of polytemozolomide combines with MGMT siRNA to enhance the effect of temozolomide in glioma
AbstractTemozolomide (TMZ) is a conventional chemotherapeutic drug for glioma, however, its clinical application and efficacy is severely restricted by its drug resistance properties. O6-methylguanine-DNA methyltransferase (MGMT) is a DNA repair enzyme, which can repair the DNA damage caused by TMZ....
Saved in:
Main Authors: | Haoyue Xu (Author), Yongkang Zhang (Author), Linfeng Li (Author), Yanhong Ren (Author), Feng Qian (Author), Lansheng Wang (Author), Hongwei Ma (Author), Ankang Quan (Author), Hongmei Liu (Author), Rutong Yu (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2023-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Advances in the management of glioblastoma: the role of temozolomide and MGMT testing
by: Thomas RP, et al.
Published: (2012) -
Concurrent hypermethylation of DNMT1, MGMT and EGFR genes in progression of gliomas
by: Gömöri Éva, et al.
Published: (2012) -
ITGA1 Promotes Glioma Cell Proliferation and Affects Immune Cell Infiltration in Low-Grade Glioma
by: Yanhong Ren, et al.
Published: (2024) -
MEOX2 promotes glioma growth and temozolomide chemoresistance
by: Tengfei Li, et al.
Published: (2024) -
A Prospective Clinical Study on MGMT Protein Expression and the Effect of Gene Promoter Methylation on Sensitivity to Chemotherapeutics in Spinal Glioma
by: Sun P, et al.
Published: (2021)